These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 31607783)

  • 1. Antidiabetic therapies and Alzheimer disease.
    Bendlin BB
    Dialogues Clin Neurosci; 2019 Mar; 21(1):83-91. PubMed ID: 31607783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer's disease.
    Alagiakrishnan K; Sankaralingam S; Ghosh M; Mereu L; Senior P
    Discov Med; 2013 Dec; 16(90):277-86. PubMed ID: 24333407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2.
    Plastino M; Fava A; Pirritano D; Cotronei P; Sacco N; Sperlì T; Spanò A; Gallo D; Mungari P; Consoli D; Bosco D
    J Neurol Sci; 2010 Jan; 288(1-2):112-6. PubMed ID: 19836029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiological Mechanisms Linking Type 2 Diabetes and Dementia: Review of Evidence from Clinical, Translational and Epidemiological Research.
    Bello-Chavolla OY; Antonio-Villa NE; Vargas-Vázquez A; Ávila-Funes JA; Aguilar-Salinas CA
    Curr Diabetes Rev; 2019; 15(6):456-470. PubMed ID: 30648514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic links between diabetes and Alzheimer's disease.
    Maher PA; Schubert DR
    Expert Rev Neurother; 2009 May; 9(5):617-30. PubMed ID: 19402773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?
    Akter K; Lanza EA; Martin SA; Myronyuk N; Rua M; Raffa RB
    Br J Clin Pharmacol; 2011 Mar; 71(3):365-76. PubMed ID: 21284695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New views and possibilities of antidiabetic drugs in treating and/or preventing mild cognitive impairment and Alzheimer's Disease.
    Zhong KL; Chen F; Hong H; Ke X; Lv YG; Tang SS; Zhu YB
    Metab Brain Dis; 2018 Aug; 33(4):1009-1018. PubMed ID: 29626315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidiabetic Drugs in the Treatment of Alzheimer's Disease.
    Michailidis M; Tata DA; Moraitou D; Kavvadas D; Karachrysafi S; Papamitsou T; Vareltzis P; Papaliagkas V
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer's Disease and Type 2 Diabetes.
    Infante-Garcia C; Ramos-Rodriguez JJ; Hierro-Bujalance C; Ortegon E; Pickett E; Jackson R; Hernandez-Pacho F; Spires-Jones T; Garcia-Alloza M
    Mol Neurobiol; 2018 Jul; 55(7):6130-6144. PubMed ID: 29224179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk of oral antidiabetic drugs: current evidence and regulatory requirements for new drugs.
    Panicker GK; Karnad DR; Salvi V; Kothari S
    J Assoc Physicians India; 2012 Jan; 60():56-61. PubMed ID: 22715547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment and diabetes.
    Dash SK
    Recent Pat Endocr Metab Immune Drug Discov; 2013 May; 7(2):155-65. PubMed ID: 23489242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
    Ou HT; Chang KC; Li CY; Wu JS
    Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment.
    Li X; Song D; Leng SX
    Clin Interv Aging; 2015; 10():549-60. PubMed ID: 25792818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetes mellitus and dementia].
    Tůma I
    Vnitr Lek; 2012 Apr; 58(4):305-8. PubMed ID: 22559805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidiabetic drugs and stroke risk. Current evidence.
    Castilla-Guerra L; Fernandez-Moreno MDC; Leon-Jimenez D; Carmona-Nimo E
    Eur J Intern Med; 2018 Feb; 48():1-5. PubMed ID: 28939005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Antidiabetic Agents and Cardiovascular Outcomes.
    Pareek M; Bhatt DL
    Curr Probl Cardiol; 2018 Mar; 43(3):111-126. PubMed ID: 28844525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights toward molecular and nanotechnological approaches to antidiabetic agents for Alzheimer's disease.
    Pradhan SP; Sahu PK; Behera A
    Mol Cell Biochem; 2023 Dec; 478(12):2739-2762. PubMed ID: 36949264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia: A Systematic Review.
    Fink HA; Jutkowitz E; McCarten JR; Hemmy LS; Butler M; Davila H; Ratner E; Calvert C; Barclay TR; Brasure M; Nelson VA; Kane RL
    Ann Intern Med; 2018 Jan; 168(1):39-51. PubMed ID: 29255847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Alzheimer's disease a type 3 diabetes? A review.
    Janoutová J; Machaczka O; Zatloukalová A; Janout V
    Cent Eur J Public Health; 2022 Sep; 30(3):139-143. PubMed ID: 36239360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.